Literature DB >> 23804186

EMA consults public on plan to increase transparency of drug trial data.

Deborah Cohen.   

Abstract

Mesh：

Year:  2013        PMID： 23804186     DOI： 10.1136/bmj.f4124

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  Discrepancies in listed adverse drug reactions in pharmaceutical product information supplied by the regulatory authorities in Denmark and the USA.

Authors:  Robert Eriksson; Lise Aagaard; Lars Juhl Jensen; Liza Borisova; Dorte Hørlück; Søren Brunak; Ebba Holme Hansen
Journal:  Pharmacol Res Perspect       Date:  2014-04-22

2.  Delays in the post-marketing withdrawal of drugs to which deaths have been attributed: a systematic investigation and analysis.

Authors:  Igho J Onakpoya; Carl J Heneghan; Jeffrey K Aronson
Journal:  BMC Med       Date:  2015-02-05       Impact factor: 8.775
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.